Effect of Arshvidya After School Program on Cognitive Processes in Elementary School Children
The impact of Arsha Vidya program on cognitive performance was examined in elementary school children. The study compares the effects of arsha vidya after school routine with usual after school routine in healthy 8-11 year-old Indian children.
The main objective of the study is to investigate the effect on cognitive function, behaviour and emotions.
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Study Type
Study Type
Enrollment (Actual)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Rajasthan
-
Jaipur, Rajasthan, India, 302019
- NMP Medical Research Institue
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Be 8 - 11 years of age at the start of the intervention
- Healthy Children
- Not start new activity within the intervention period
- Parental conset
- Parents to allow and participate where needed in intervention
Exclusion Criteria:
- Serious chronic illnesses and diseases
- Diagnosed with any psychiatric illness
- Intake of medication that may affect study outcomes
- not able to continue for 12-weeks of participation
Study Plan
How is the study designed?
Design Details
- Primary Purpose: OTHER
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: NONE
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
EXPERIMENTAL: Arsha Vidya Group
After school, children joined regular sessions in Arsha Vidya study centre to practice, vedic chants, vedanta reading, yoga and group activities within the ashram.
|
Yoga, Vedic chants, Vedant sessions, Gita sessions and group activities within the Gurukulam (centre)
|
|
OTHER: Usual Activity Group
After school, control group were asked to conitue their usual routine.
|
Usual after school activities at home.
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Cognitive function
Time Frame: Change from baseline to 12-week
|
Cognitive functions measured by the Cambridge Neuropsychological Test Automated Battery
|
Change from baseline to 12-week
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Behaviour
Time Frame: Change from Baseline to 12-weeks
|
Behaviour measured by the Behavior Rating Inventory of Executive Function
|
Change from Baseline to 12-weeks
|
|
Attention
Time Frame: Change from baseline to 12-weeks
|
Attention measured by the D2 Test of Attention
|
Change from baseline to 12-weeks
|
Collaborators and Investigators
Sponsor
Sponsor
Collaborators
Collaborators
Investigators
Investigators
- Study Director: Puneet Sharma, Sarvatra International, Dubai
Study record dates
Study Major Dates
Study Start (ACTUAL)
Study Start
Primary Completion (ACTUAL)
Primary Completion
Study Completion (ACTUAL)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (ACTUAL)
First Posted
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
Other Study ID Numbers
- NMP/ Arsha/0092
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.